Isokinetic Strength and Anaerobic Capacity (NCT07376551) | Clinical Trial Compass
CompletedNot Applicable
Isokinetic Strength and Anaerobic Capacity
Turkey (Türkiye)80 participantsStarted 2026-01-05
Plain-language summary
This study aims to investigate differences in isokinetic knee extensor and flexor strength parameters among recreationally active young adult males classified into low, moderate, and high anaerobic power groups based on relative peak power (W/kg) obtained from the Wingate Anaerobic Test. Eighty male participants aged 22-30 years, engaging in regular physical activity, will undergo body composition analysis, isokinetic strength testing at 60°/s, and a 30-second Wingate test performed on separate days. Participants will be grouped according to median-based anaerobic power classification to allow meaningful group comparisons. Group differences in peak torque and total work will be analyzed using ANOVA or non-parametric equivalents, and relationships between Wingate parameters and isokinetic strength will be examined using correlation analyses. The findings are expected to provide novel insights into the relationship between anaerobic power classification and lower-extremity muscle strength profiles, contributing to performance profiling and training planning in recreationally active populations.
Who can participate
Age range
20 Years – 32 Years
Sex
MALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Male participants aged between 20 and 30 years
* Moderately physically active individuals, as defined by the International Physical Activity Questionnaire (IPAQ)
* Apparently healthy, with no known neurological, vestibular, or musculoskeletal disorders affecting balance
* Ability to stand independently and complete balance assessments
* Willingness to participate and provide written informed consent
Exclusion Criteria:
* History of lower-limb, spine, or pelvic injury or surgery within the past 6 months
* Presence of acute or chronic pain affecting posture or balance
* Diagnosed neurological, vestibular, or balance disorders
* Use of medications or substances that may affect neuromuscular function or postural control
* Participation in another clinical or observational study within the past 3 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Isokinetic knee extensor and flexor peak torque (Nm) at 60°/s
Timeframe: day 1 (Assessed during a single laboratory testing session.)